About Mayne Pharma

Mayne Pharma Group Limited (Mayne Pharma) is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals, providing patients with access to better and more accessible medicines. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.

Mayne Pharma’s roots can be traced to FH Faulding and Co, for many years one of the largest and most prominent public companies headquartered in South Australia.

A technology driven company, Mayne Pharma has a significant product portfolio and pipeline, global reach through distribution partners in Australia, North America, Europe and Asia and two product development and manufacturing facilities based in Salisbury, Australia and Greenville, North Carolina, USA with expertise in formulating complex oral and topical dose forms including highly potent compounds, modified release products and poorly soluble compounds. The business is supported by over 900 staff globally with more than 200 scientists employed.